RSV vaccine protects older adults against severe illness
A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. “This Kaiser Permanente research demonstrated the real-world effectiveness of RSV vaccination among ...
Featured News
Study finds air pollution may increase risk of preterm birth
Exposure to a specific kind of air pollution, fine particulate matter, during pregnancy may significantly increase the risk of spontaneous preterm birth, which can be dangerous for both the mother and ...
5 questions for … Dr. Javed Sheikh
Javed Sheikh, MD, was recently named 2024 Physician Researcher of the Year by the Southern California Permanente Medical Group. Dr. Sheikh is the vice area research chair for the Los Angeles area on ...
Kaiser Permanente’s vaccine side-effect monitor bolsters safety
After COVID-19 vaccines became available in December 2020, several smartphone-based reporting systems were developed to monitor vaccine side effects. They included V-safe from the Centers for Disease ...
Five questions for … Dr. Huong Nguyen
May 3, 2024A nurse and health services researcher, Huong Q. Nguyen, PhD, RN, focuses her research on the care of older adults with chronic and serious illnesses. She is the co-lead of the Care Improvement Research Team and interim director of the Division of Health Services Research & Implementation for the Department of Research & Evaluation. She ...Read more...Q&A with Physician Researcher of the Year: Dr. Michael Fassett
February 7, 2024Michael J. Fassett, MD, came to work at Kaiser Permanente in 2000. Since then, his dedication to his patients through research has grown. He’s published more than 50 research papers in peer-reviewed journals. Now, as the regional physician-in-charge for Maternal-Fetal Medicine and the area research chair for the West Los Angeles and Kern County service ...Read more...Five questions for … Dr. Annette Langer-Gould
December 20, 2023Annette Langer-Gould, MD, PhD, is a translational neuroscientist with the Southern California Permanente Medical Group. She treats people with multiple sclerosis (MS) at the Kaiser Permanente Los Angeles Medical Center. Dr. Langer-Gould joined Kaiser Permanente in 2009. Her research aims to deepen understanding of MS while improving quality of care. Recently, she co-authored an editorial in ...Read more...COVID bivalent booster protects well against hospitalization
December 4, 2023A Kaiser Permanente study shows the Pfizer-BioNTech BNT162b2 BA.4/5 bivalent mRNA vaccine helped protect against a range of COVID symptoms and was effective against the COVID XBB strain sublineages. The most substantial benefit of the bivalent vaccine booster was keeping people out of the hospital and keeping people from becoming critically ill. The study was ...Read more...Kaiser Permanente Southern California to lead CDC-funded center to improve outbreak and disease prediction
October 18, 2023Kaiser Permanente Southern California has been tapped to lead an innovation center that will develop advanced modeling approaches to better predict disease outbreaks and prepare the United States for future public health emergencies. The center is 1 of 13 sites that will form the Outbreak Analytics and Disease Modeling Network, a national initiative funded by the ...Read more...Diabetes increased among kids during pandemic
September 25, 2023A study of more than 1 million Kaiser Permanente members ages 19 and younger found that rates of both type 1 and type 2 diabetes increased among children during the COVID-19 pandemic, particularly for those ages 10 and older, male children, and children in specific racial and ethnic groups. The study was published September 21, ...Read more...Kaiser Permanente cancer survival rates higher
September 25, 2023Kaiser Permanente had better 5-year survival rates among breast, colorectal, and lung cancer patients compared to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) estimates, according to research published in September 2023 in The Permanente Journal. Researchers in all 8 Kaiser Permanente regions worked together on this study. They compared the occurrence of cancer ...Read more...Five questions for … Dr. Emily Rayens
September 18, 2023Emily Rayens, PhD, MPH, is a postdoctoral research fellow in the Division of Epidemiologic Research of the Department of Research & Evaluation. Her research interests include infectious diseases and vaccine efficacy and safety. She began her fellowship at Kaiser Permanente in 2023, but it is her third year as a postdoctoral fellow. She was previously ...Read more...Five questions for … Dr. Titilola Labisi
September 18, 2023Titilola Labisi, PhD, MHA, MPH, is a public health researcher and a postdoctoral research fellow in the Division of Behavioral Research of the Department of Research & Evaluation. She joined the department in 2022. Her research interests include community-engaged research, health disparities, and health behaviors related to sex, diet, and physical activity. She previously worked ...Read more...Five questions for … Dr. Nehaa Khadka
September 18, 2023Nehaa Khadka, PhD, MPH, is a maternal/child health epidemiologist and postdoctoral research fellow in the Division of Epidemiologic Research of the Department of Research & Evaluation. Her research interests include perinatal epidemiology, reproductive health, and health disparities. She began her fellowship in June 2023. While pursuing her doctorate degree at the UCLA Fielding School of ...Read more...